Papers associated with chuk

???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest

Sort Oldest To Newest

	Treatment of Retinoblastoma 1-Intact Hepatocellular Carcinoma With Cyclin-Dependent Kinase 4/6 Inhibitor Combination Therapy., Sheng J, Kohno S, Okada N, Okahashi N, Teranishi K, Matsuda F, Shimizu H, Linn P, Nagatani N, Yamamura M, Harada K, Horike SI, Inoue H, Yano S, Kumar S, Kitajima S, Ajioka I, Takahashi C., Hepatology. October 1, 2021; 74 (4): 1971-1993.
	Prognostic significance of TPX2 and NIBP in esophageal cancer., Sui C, Song Z, Yu H, Wang H., Oncol Lett. October 1, 2019; 18 (4): 4221-4229.
	Mechanism of vaccinia viral protein B14-mediated inhibition of IκB kinase β activation., Tang Q, Chakraborty S, Xu G., J Biol Chem. June 29, 2018; 293 (26): 10344-10352.
	Phosphorylation of Xenopus p31(comet) potentiates mitotic checkpoint exit., Mo M, Arnaoutov A, Dasso M., Cell Cycle. January 1, 2015; 14 (24): 3978-85.
	Crystal structure of a human IκB kinase β asymmetric dimer., Liu S, Misquitta YR, Olland A, Johnson MA, Kelleher KS, Kriz R, Lin LL, Stahl M, Mosyak L., J Biol Chem. August 2, 2013; 288 (31): 22758-67.
	A structural basis for IκB kinase 2 activation via oligomerization-dependent trans auto-phosphorylation., Polley S, Huang DB, Hauenstein AV, Fusco AJ, Zhong X, Vu D, Schröfelbauer B, Kim Y, Hoffmann A, Verma IM, Ghosh G, Huxford T., PLoS Biol. January 1, 2013; 11 (6): e1001581.
	Crystal structure of the ubiquitin-like domain of human TBK1., Li J, Li J, Miyahira A, Sun J, Liu Y, Cheng G, Liang H., Protein Cell. May 1, 2012; 3 (5): 383-91.
	Crystal structure of inhibitor of κB kinase β., Xu G, Lo YC, Li Q, Napolitano G, Wu X, Jiang X, Dreano M, Karin M, Wu H., Nature. April 21, 2011; 472 (7343): 325-30.
	Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors., Landais I, Hiddingh S, McCarroll M, Yang C, Sun A, Turker MS, Snyder JP, Hoatlin ME., Mol Cancer. December 31, 2009; 8 133.
	Anti-breast cancer activity of LFM-A13, a potent inhibitor of Polo-like kinase (PLK)., Uckun FM, Dibirdik I, Qazi S, Vassilev A, Ma H, Mao C, Benyumov A, Emami KH., Bioorg Med Chem. January 15, 2007; 15 (2): 800-14.
	[Role of MyD88-dependent nuclear factor-kappaB signaling pathway in the development of cardiac hypertrophy in vivo]., Li YH, Ha TZ, Chen Q, Li CF., Zhonghua Yi Xue Za Zhi. January 26, 2005; 85 (4): 267-72.
	IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain., Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W., J Biol Chem. October 22, 1999; 274 (43): 30353-6.

???pagination.result.page??? 1